Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Incyte (INCY) -- Ignore unavailable to you. Want to Upgrade?

To: Scott who wrote (976)	4/13/1999 4:16:00 PM
From: LLCF	Read Replies (1) \| Respond to of 3202

"BT Alex Brown reiterates Strong Buy... Kevin Tang tells sales force that INCY announced that the U.S. patent and Trademark Office declared patent interference proceedings involving two AFFYMETRIX patents, pending patent applications licensed exclusively to INCYTE...." "Also believes interference proceedings bode well for INCY because they may reder it unlikely that a judge will grant AFFX's request for preliminary injunction, since patent involved is subject of ongoing proceedings... Also, proceedings could result in AFFX having one or both patents weakened or revoked... has 34 1/2 12-mo. target." Bloomberg DAK